Qilu Pharmaceutical Co., Ltd.
Jinan, China
Works in Cardiovascular · Dermatology · ENT · Genetic & rare · GI & liver · Hematology · Immunology · Infectious disease · Metabolic & endocrine · Musculoskeletal · Neurology · Oncology · Ophthalmology · Psychiatry · Renal & urogenital · Respiratory · Women's health
Qilu Pharmaceutical Co., Ltd. is a clinical trial sponsor based in Jinan, China. It has 102 active clinical trials with 28,325 planned participants, across 17 therapeutic areas. Since 2021 it has completed 27 trials and stopped 1 early. Its FDA record on file shows 1 inspection.
Trial track record · since 2021
FDA record
Recent FDA actions
Pipeline · 102 active trials
| Stage | Trial | Status |
|---|---|---|
Questions about Qilu Pharmaceutical Co., Ltd
No warning letter naming Qilu Pharmaceutical Co., Ltd is on file. FDA has published 1 inspection classification naming it.
FDA has posted 1 inspection classification naming Qilu Pharmaceutical Co., Ltd. The latest inspection ended on 2026-05-08 and was classified VAI (voluntary action indicated). FDA posts a classification after its review, often months after the inspection ended.
Qilu Pharmaceutical Co., Ltd is lead sponsor of 102 active clinical trials on ClinicalTrials.gov, with 28,325 planned participants, in Cardiovascular, Dermatology, ENT, Genetic & rare and other areas. Since 2021 it has completed 27 trials and stopped 1 early.
Qilu Pharmaceutical Co., Ltd is based in Jinan, China. The address is the one on its FDA records or ClinicalTrials.gov registrations, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Qilu Pharmaceutical Co., Ltd; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-10-14.
The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.
Approve Suite is not affiliated with Qilu Pharmaceutical Co., Ltd.. Informational only.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.